With relief cut to 20%, are VCTs still worth it?

Are VCTs still worth it? Following changes in the 2025 Autumn Budget, from 6 April 2026, upfront income tax relief on new VCT subscriptions dropped from 30% to 20% — and the implications cut deeper than the headline suggests.

For two decades, VCTs have sold themselves on a simple pitch: accept the fees, accept the five-year lock-up, and a generous tax rebate will smooth over whatever the underlying portfolio does. Plus the potential for  tax-free dividends to sweeten the deal. That pitch just got 10 percentage points weaker.

With a thinner tax cushion, investors can no longer rely on government rebates to mask high fees and mediocre returns. The change exposes a structural question that's been quietly ignored for years: once you strip away the tax wrapper, are VCTs actually delivering venture-grade returns?

This new era of venture capital demands a clinical focus on raw performance — and a hard look at whether EIS, with its unchanged 30% income tax relief and better portfolio economics, is now the smarter home for risk capital. Tax treatment depends on individual circumstances and may be subject to change.

With VCT relief now at 20%, the gap between VCT and EIS has widened beyond the tax wrapper.

EIS still offers 30% upfront relief and adds loss relief against income tax if investments fail — downside protection that VCTs don't provide. But the bigger structural advantage is portfolio design.

Research into the UK startup market shows that return multiples follow a power-law distribution with an exponent (alpha) of 1.8 (Graham Schwikkard, The Science of Startup Investing, 2022). A small number of companies generate the majority of returns. 

 

The practical implication is that portfolio size matters — but so does stage. VCTs typically hold large portfolios of later-stage companies, where the biggest multiples have already been compressed. Most EIS funds do the opposite: they invest at the right stage but concentrate capital into just six to ten companies, statistically too few to reliably catch an outlier.

Access EIS was built to close this gap. By co-investing alongside the UK's top-performing angels, it assembles portfolios of 30+ early-stage startups — combining the stage advantage of EIS with the diversification needed to capture power-law winners.

Investing with the UK's top-performing Angel Investors

 

SyndicateRoom's Access EIS Fund builds on a simple premise: to identify angel investors with verifiable, top-decile track records in UK early-stage investing and co-invest alongside them.

These aren't anonymous picks — they're angels whose portfolio performance has been independently tracked across multiple cycles, and they've been filtered from a dataset of thousands of UK angel investors.

For example, one of the angels SyndicateRoom co-invests with has achieved a 126% IRR by taking early positions in companies including Adzuna (acquired by Recruit Holdings) and Tandem (now a publicly listed digital bank).

The approach centres on three principles:

• Sector focus: concentrated expertise in fintech and marketplace models rather than generalist allocation
• Early conviction: taking positions at seed or pre-seed, before valuations inflate in later rounds
• Pro-rata rights: maintaining equity percentage through follow-on rounds to compound on winners

This isn't luck. It's systematic access to deals most retail investors never see, and that VCT structures may only reach in later, more expensive rounds.

The result is a fund that targets the power-law distribution of venture returns rather than relying on the tax wrapper to do the heavy lifting.

 

 When VCTs may still make sense

 

Despite the relief cut, VCTs retain advantages for specific investors. Those seeking tax-free dividend income (rather than capital growth) may still find VCTs attractive. Investors who have maxed out their pension allowances and want liquid-ish public-market exposure to UK small companies have fewer alternatives. And for those uncomfortable with EIS-level early-stage risk, the more mature company profile within a VCT may better suit their risk appetite.

The question isn't whether VCTs have a place — it's whether they should remain a default choice at 20% relief.

Frequently asked questions

 

Will existing VCT investments be affected?
No. The reduction to 20% applies only to new subscriptions made after 6 April 2026. Relief claimed on existing holdings remains at the rate applicable at the time of the investment.

What are the key differences between VCT and EIS?
VCTs invest in later-stage companies and typically offer tax-free dividend income, with a five-year holding period. EIS invests in earlier-stage companies and offers higher upfront relief (30%), loss relief against income tax if investments fail, and a shorter three-year minimum hold. VCTs tend to suit income-focused investors; EIS tends to suit those targeting capital growth and willing to accept early-stage risk for higher return potential.

Can I invest in both VCTs and EIS?
Yes. The annual allowances are separate: £200,000 for VCTs and £1 million for EIS (£2 million if investing in knowledge-intensive companies). Combining both provides diversification across company stages and tax treatment structures.

 

 

VCT vs EIS: the numbers on £100k invested

 

On £100k invested	VCT (new)	EIS
Upfront relief	£20,000	£30,000
Loss relief on failures	None	Up to 45% of loss
Typical portfolio size	10–15 companies	30+ (diversified funds)
Minimum hold	5 years	3 years

 Compare: EIS and VCT